Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant Covaxin meets the WHO efficacy criteria for COVID-19 vaccines for the dreaded Delta variants, the company said. https://ift.tt/eA8V8J